Back
Pioneer Natural Resources Vs. Keros Therapeutics Industry Stock Comparison
Sell
50
PXD
Pioneer Natural Resources
Last Price:
270.28
Seasonality Move:
1.63%
Sell
39
KROS
Keros Therapeutics
Last Price:
58.34
Seasonality Move:
-16.78%
Sell
50
Pioneer Natural Resources (PXD)
is a Sell
Is Pioneer Natural Resources a Buy, Sell or Hold?
- The current Pioneer Natural Resources [PXD] share price is $270.31. The Score for PXD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- PXD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $58.44. The Score for KROS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PXD Stock Price Chart
What is Pioneer Natural Resources's stock price today?
-
The Pioneer Natural Resources share price today is $270.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PXD is experiencing slight selling pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $58.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
PXD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.63 | Buy |
| Relative Strength Index (14 RSI): | 66.22 | Buy |
| Chaikin Money Flow: | -817097 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.78 - 272.06) | Buy |
| Bollinger Bands (100): | (221.42 - 254.94) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.56 | Sell |
| Relative Strength Index (14 RSI): | 39.95 | Sell |
| Chaikin Money Flow: | 64919 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.99 - 66.47) | Sell |
| Bollinger Bands (100): | (40.86 - 66.12) | Buy |
PXD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 270.4 | Sell |
| 20-day SMA: | 267.24 | Buy |
| 50-day SMA: | 249.99 | Buy |
| 200-day SMA: | 235.23 | Buy |
| 8-day EMA: | 269.32 | Buy |
| 20-day EMA: | 265.59 | Buy |
| 50-day EMA: | 254.2 | Buy |
| 200-day EMA: | 237 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.24 | Sell |
| 20-day SMA: | 62.47 | Sell |
| 50-day SMA: | 63.41 | Sell |
| 200-day SMA: | 43.93 | Buy |
| 8-day EMA: | 59.56 | Sell |
| 20-day EMA: | 61.56 | Sell |
| 50-day EMA: | 60.78 | Sell |
| 200-day EMA: | 49.53 | Buy |
Pioneer Natural Resources Earnings Growth & PXD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.04 per share, an increase this year of $0.32 per share, and an increase next year of $1.23 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Pioneer Natural Resources Technical Analysis
| Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||